Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Adicet Bio shares promising look at CAR-T for lupus, but stock drops anyway

Adicet Bio reported that its off-the-shelf CAR-T therapy improved symptoms for lupus patients in an early-stage study, and it plans to soon start a pivotal trial. The Bay Area company in ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Finance & Markets

Valley Bank Courts Small Businesses With Bluevine Acquisition

Valley Bank is set to acquire Bluevine, a digital banking platform for small businesses. The $340 million deal is designed to help Valley with its efforts to strengthen its funding base, expand its small business franchise, and accelerate its digital and artificial intelligence (AI) strategy, the bank said in a Monday (Sept.

More from Monday 28 September →